Abbott (NYSE: ABT) is turning to Google’s artificial intelligence expertise to leverage more glucose insights for users of the Abbott Park, Illinois–based life science giant’s Lingo biowearable. Under a multiyear agreement announced today, ongoing glucose insights from Abbott’s Lingo biowearable will combine with Google Health’s technology to provide a more comprehensive view of people’s health. […]
Big Data
Clinical Ink, Tandem Diabetes Care partner on automated insulin delivery data
Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care (Nasdaq:TNDM) to integrate automated insulin delivery (AID) data. The collaboration enables the integration of Tandem’s t:slim X2 and Mobi AID systems with Clinical Ink’s GlucoseReady platform. This would provide an automated method for capturing AID system data in clinical trials. In the partnership, […]
Tidepool, Oura partner on data for diabetes research
Tidepool today announced a strategic collaboration with Oura to support a groundbreaking dataset for diabetes research. The initiative between the diabetes software developer and smart ring maker aims to create a comprehensive, multi-modal, real-world dataset for diabetes, utilizing Tidepool’s diabetes device data paired with biometric data collected by the leading Oura Ring Gen 3. This […]
FriskAI, Dexcom to integrate CGM data into AI management platform
FriskAi announced today that it entered into an agreement with Dexcom to integrate data into its AI-powered healthcare platform. The deal enables the integration of G7 and G6 continuous glucose monitor (CGM) data into the FriskAI platform. Arlington, Virginia-based FriskAi designed its platform to support physicians and patients with actionable personalized care management programs. FriskAI’s […]
Tidepool launches cloud integration with Abbott CGM
Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre CGM portfolio. In October 2024, the companies announced a collaboration to deliver cloud-to-cloud integration for an automatic stream of data for patients using Abbott continuous glucose monitors (CGMs) in the U.S. “Every day at Tidepool, we work to […]
Abbott integrates Libre CGM data into Epic EHR workflows
Abbott (NYSE:ABT) announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR systems. The partnership enables the integration of data from the Libre continuous glucose monitor (CGM) systems directly into Epic EHR in the U.S. Through this collaboration, the companies aim to improve workflow efficiency for providers […]
Tidepool achieves new certification for open-source quality management system
Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS. Palo Alto, California-based Tidepool, a non-profit diabetes data management group, develops open-source technology for the diabetes community. That includes the FDA-cleared Tidepool Loop, a “do-it-yourself” (DIY) automated insulin delivery (AID) system. Recent collaborations include integrations with Abbott and Sequel […]
Satio, Nanowear collab to bring AI-powered biomarkers to drug delivery
Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care. The collaboration aims to integrate Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches. This would combine time-synchronous, in vivo and in vitro diagnostics for precision therapeutics and individualized AI-based risk […]
Nanowear enters CGM licensing, data partnership with Dexcom
Nanowear announced today that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose monitors (CGMs). The partnership will see Nanowear’s SimpleSense nanotechnology-enabled wearable, mobile and software diagnostics platform take data from the Dexcom G7 CGM, combining continuous glucose readings, blood pressure, ECGs, lung volume, respiration and hemodynamics. This […]
Glooko, Innovation Zed partner on digital companion apps for injection therapy management
Glooko and Innovation Zed today announced a strategic partnership to develop and deploy digital companion apps for injectable therapies. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. Ireland-based Innovation Zed develops insulin […]
